SnagRx vs Directmeds: Compounded GLP-1 Pricing and Services Compared
Quick verdict: SnagRx is the lower-cost, price-locked annual option for compounded semaglutide while Direct Meds emphasizes transparent standard pricing, injectable and sublingual formats, and month-to-month flexibility.
SnagRx vs Directmeds is primarily a choice between an annual, price-locked, bottom-of-market compounded plan and a provider that advertises promotional pricing with clear standard FAQ rates and multiple formulation options. The early verdict: choose SnagRx if you want the lowest annual rate and a price lock; choose Direct Meds if you value standard transparent pricing and injectable or sublingual options.
View SnagRx $69/mo annual plan
Key differences at a glance
| Criteria | SnagRx | Direct Meds |
|---|---|---|
| Advertised starting price | From $69/month semaglutide (12-month plan) | Promotional starting price $147; FAQ standard $297/month |
| Price structure | Price locked flat at every dose and renewal on annual plan | Promotions available; standard FAQ pricing listed; subscribe terms vary |
| Formulations | Compounded semaglutide and tirzepatide (injectable) | Compounded injectable and sublingual semaglutide and tirzepatide |
| Shipping and supplies | Next-day UPS/FedEx temperature-controlled shipping; injection supplies included | Free next-day UPS/FedEx temperature-controlled shipping; supplies included |
| Clinician and pharmacy network | Named US 503A pharmacies; OpenLoop Health clinician network covering 48 states | U.S.-based 503A compounding pharmacies; availability excludes Mississippi and Louisiana |
| Cancellation and refunds | No monthly membership; cancel anytime; full refund if prescription declined | No monthly membership fee; month-to-month cancellation; full refund if prescription not approved |
Pricing and billing: annual lock versus promotional and FAQ rates
Pricing is the clearest dividing line. SnagRx advertises compounded semaglutide from $69/month and tirzepatide from $119/month on the 12-month plan, with the site stating the rate is locked flat at every dose and at renewal. SnagRx also quotes month-to-month prices of $99 and $149 for those who do not commit to 12 months. Direct Meds promotes a starting price of $147 and notes a summer promotion that saves $150, but its FAQ lists standard rates of $297/month for semaglutide and $399/month for tirzepatide. The comparison is therefore between a low locked annual rate and a provider with higher standard rates plus promotional offers.
See Direct Meds promotional pricing
Formulation and delivery options
SnagRx focuses on compounded injectable semaglutide and tirzepatide supplied by named US 503A pharmacies. Direct Meds offers both injectable and sublingual compounded formulations of semaglutide and tirzepatide. If formulation choice is important, Direct Meds explicitly lists sublingual and injectable options while SnagRx emphasizes compounded injectable products.
Clinician network, pharmacy partners, and availability
SnagRx names its four US 503A partner pharmacies and states medical care is delivered by OpenLoop Health, a network of US-licensed clinicians covering 48 states. Direct Meds also uses U.S.-based 503A compounding pharmacies and states the service is not available in Mississippi or Louisiana. Both providers state prescriptions are subject to clinician review and that a full refund applies if a prescription is declined or not approved.
Shipping, supplies, and cancellation
Both providers advertise next-day temperature-controlled UPS or FedEx shipping and include supplies and clinician reviews in the price. SnagRx highlights next-day shipping and says OpenLoop clinicians typically review intake within five hours and always within 24. Both platforms advertise no separate monthly membership fee and allow cancellation; Direct Meds clarifies month-to-month cancellation is available while discounted subscribe-and-save plans require the stated term.
Safety and regulatory notes
Both providers make the regulatory point that compounded medications are not FDA-approved and are not reviewed by FDA for safety, effectiveness or quality. SnagRx adds that their compounded medications are produced in FDA-regulated facilities but are not FDA-approved finished products and that OpenLoop Health clinicians apply exclusionary criteria to determine medical appropriateness. Direct Meds similarly states treatment is available only when a licensed clinician determines it is medically appropriate.
Compare SnagRx clinician process
Which provider fits you? Choose based on these facts
- Choose SnagRx if you want compounded semaglutide from $69/month on a 12-month plan and value a price lock flat at every dose and renewal.
- Choose Direct Meds if you prefer a provider that advertises promotional pricing with clear standard FAQ rates and offers injectable and sublingual compounded formats with month-to-month cancellation.
Start SnagRx annual plan enrollment
Check Direct Meds standard pricing and formats
Summary: For SnagRx vs Directmeds the trade off is clear. SnagRx offers the lowest annual compounded price with a lifetime price lock on dose escalation. Direct Meds highlights promotional and FAQ pricing, month-to-month options, and an added sublingual format. Both use US 503A pharmacies, include clinician review and shipping, and state that compounded medications are not FDA-approved.